As shown in Fig. 2b, miR-9 was differentially expressed in the breast cancer molecular subgroups (p < 0.001 Kruskall-Wallis test), with the highest expression levels in the basal like and HER2 enriched PAM50 subtypes, and the lowest in the two luminal subtypes. The gene discussed is ERBB2; the disease is breast cancer.